ENDO 2020

June 10, 2020

Virtual, United States

Primary prevention of ascvd and t2dm in patients at metabolic risk an endocrine society clinical practice guideline

Please log in to leave a comment


Transcript English (automatic)

Next from ENDO 2020

technical paper

Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome

ENDO 2020

Thomas O. Carpenter and 9 other authors

10 June 2020

Similar lecture

technical paper

Transition of Care for Transgender Youth

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!


  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved